| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.048 | 0.3 |